WASHINGTON (Reuters) - More frequent screening for prostate cancer, as expected, found more tumors, but failed to cut the number of aggressive tumors detected in between scheduled screenings, European researchers said on Tuesday.The findings, published in the Journal of the National Cancer Institute, added to the controversy over the value of screening tests for this common cancer among men and how frequently they should be performed.
